Skip to content

BillionToOne

US · BLLN #2109 by market cap Listed 2025
89.92 -0.28 -0.31%
Periodic snapshot; not a real-time feed. · 2026-11-20 20:01

Recent news

  • Rating change
    CCORF Initiates BillionToOne(BLLN.US) With Buy Rating, Announces Target Price $120
    Market Newswire · 2026/9/2
  • Rating change
    Guggenheim Maintains BillionToOne(BLLN.US) With Buy Rating, Raises Target Price to $125
    Market Newswire · 2026/6/29
  • Rating change
    Analysts Offer Insights on Healthcare Companies: TruBridge (TBRG) and BillionToOne, Inc. Class A (BLLN)
    TipRanks · 2026/4/13
  • Rating change
    J.P. Morgan Maintains BillionToOne(BLLN.US) With Buy Rating, Raises Target Price to $145
    Market Newswire · 2026/7/22
  • Rating change
    Analysts Offer Insights on NA Companies: BillionToOne, Inc. Class A (BLLN) and MBX Biosciences, Inc. (MBX)
    TipRanks · 2026/8/7
  • Guggenheim Maintains BillionToOne(BLLN.US) With Buy Rating, Raises Target Price to $128
    Market Newswire · 2026/10/1
  • Piper Sandler Maintains BillionToOne(BLLN.US) With Buy Rating, Cuts Target Price to $130
    Market Newswire · 2026/11/10
  • Rating change
    Analysts Have Conflicting Sentiments on These Healthcare Companies: BillionToOne, Inc. Class A (BLLN) and Bio-Techne (TECH)
    TipRanks · 2026/5/7
  • J.P. Morgan Maintains BillionToOne(BLLN.US) With Buy Rating, Cuts Target Price to $135
    Market Newswire · 2026/11/5
  • Rating change
    Analysts Are Bullish on These NA Stocks: BillionToOne, Inc. Class A (BLLN), Carlsmed, Inc. (CARL)
    TipRanks · 2026/8/6
  • A Quick Look at Today's Ratings for BillionToOne(BLLN.US), With a Forecast Between $120 to $145
    Market Newswire · 2026/11/6
  • Rating change
    Analysts Offer Insights on Healthcare Companies: BillionToOne, Inc. Class A (BLLN), ACADIA Pharmaceuticals (ACAD) and Revolution Medicines (RVMD)
    TipRanks · 2026/5/7
  • Rating change
    J.P. Morgan Maintains BillionToOne(BLLN.US) With Buy Rating, Maintains Target Price $120
    Market Newswire · 2026/4/13
  • Rating change
    BTIG Maintains BillionToOne(BLLN.US) With Buy Rating, Raises Target Price to $142
    Market Newswire · 2026/7/23
  • Rating change
    Analysts Offer Insights on Healthcare Companies: Bristol-Myers Squibb (BMY), BillionToOne, Inc. Class A (BLLN) and Solventum Corporation (SOLV)
    TipRanks · 2026/5/25
  • Rating change
    William Blair Initiates BillionToOne(BLLN.US) With Buy Rating
    Market Newswire · 2026/8/7
  • Rating change
    A Quick Look at Today's Ratings for BillionToOne(BLLN.US), With a Forecast Between $100 to $145
    Market Newswire · 2026/5/7
  • Rating change
    Guggenheim Maintains BillionToOne(BLLN.US) With Buy Rating, Raises Target Price to $120
    Market Newswire · 2026/5/13
  • Piper Sandler Maintains BillionToOne(BLLN.US) With Buy Rating, Raises Target Price to $140
    Market Newswire · 2026/11/5
  • Rating change
    Stifel Nicolaus Keeps Their Buy Rating on BillionToOne, Inc. Class A (BLLN)
    TipRanks · 2026/5/7
  • Form 144 | BillionToOne(BLLN.US) Officer Proposes to Sell 3.87 Million in Common Stocks
    Market Newswire · 2026/9/18
  • BillionToOne(BLLN.US) Officer Sells US$3.87 Million in Common Stock
    Market Newswire · 2026/9/22
  • BillionToOne(BLLN.US) Officer Sells US$3.03 Million in Common Stock
    Market Newswire · 2026/9/17
  • Rating change
    Piper Sandler Maintains BillionToOne(BLLN.US) With Buy Rating, Cuts Target Price to $130
    Market Newswire · 2026/5/7

Headlines are aggregated automatically and are not independently verified or edited by our team.

Quote time 2026-11-20 20:01:12 · For reference only, not investment advice and not tailored to your situation.

BillionToOne discussion 0 comments

Add a comment